Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ
Zmień bibliotekę

Wyszukujesz frazę ""influenza"" wg kryterium: Temat


Tytuł :
Rare variant MX1 alleles increase human susceptibility to zoonotic H7N9 influenza virus.
Autorzy :
Chen Y; School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, China.
Graf L; Institute of Virology, Medical Center - University of Freiburg, Freiburg, Germany.; Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Chen T; Chinese National Influenza Center, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Liao Q; School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, China.
Bai T; Chinese National Influenza Center, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Petric PP; Institute of Virology, Medical Center - University of Freiburg, Freiburg, Germany.; Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Spemann Graduate School of Biology and Medicine, University of Freiburg, Freiburg, Germany.
Zhu W; Chinese National Influenza Center, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Yang L; Chinese National Influenza Center, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Dong J; Chinese National Influenza Center, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Lu J; Chinese National Influenza Center, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Chen Y; BGI-Shenzhen, Shenzhen, China.
Shen J; BGI-Shenzhen, Shenzhen, China.
Haller O; Institute of Virology, Medical Center - University of Freiburg, Freiburg, Germany.; Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Department of Molecular Life Sciences, University of Zurich, Zurich, Switzerland.
Staeheli P; Institute of Virology, Medical Center - University of Freiburg, Freiburg, Germany.; Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Kochs G; Institute of Virology, Medical Center - University of Freiburg, Freiburg, Germany.; Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Wang D; Chinese National Influenza Center, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China. .
Schwemmle M; Institute of Virology, Medical Center - University of Freiburg, Freiburg, Germany. .; Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Shu Y; School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, China. .; Chinese National Influenza Center, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Pokaż więcej
Źródło :
Science (New York, N.Y.) [Science] 2021 Aug 20; Vol. 373 (6557), pp. 918-922.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Influenza A Virus, H7N9 Subtype*/physiology
Influenza, Human/*genetics
Influenza, Human/*virology
Myxovirus Resistance Proteins/*genetics
Agricultural Workers' Diseases/genetics ; Agricultural Workers' Diseases/virology ; Animals ; Cell Line ; Genetic Predisposition to Disease ; Genetic Variation ; Heterozygote ; Humans ; Influenza A virus/physiology ; Mutation, Missense ; Myxovirus Resistance Proteins/chemistry ; Myxovirus Resistance Proteins/metabolism ; Poultry ; Viral Zoonoses ; Whole Genome Sequencing
Czasopismo naukowe
Tytuł :
Effects of Prior Season Vaccination on Current Season Vaccine Effectiveness in the United States Flu Vaccine Effectiveness Network, 2012-2013 Through 2017-2018.
Autorzy :
Kim SS; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.; Oak Ridge Institute for Science and Education, Oak Ridge, Tennessee, USA.
Flannery B; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Foppa IM; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Chung JR; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Nowalk MP; University of Pittsburgh Schools of the Health Sciences, Pittsburgh, Pennsylvania, USA.
Zimmerman RK; University of Pittsburgh Schools of the Health Sciences, Pittsburgh, Pennsylvania, USA.
Gaglani M; Baylor Scott and White Health, Texas A&M University College of Medicine, Temple, Texas, USA.
Monto AS; University of Michigan School of Public Health, Ann Arbor, Michigan, USA.
Martin ET; University of Michigan School of Public Health, Ann Arbor, Michigan, USA.
Belongia EA; Marshfield Clinical Research Institute, Marshfield, Wisconsin, USA.
McLean HQ; Marshfield Clinical Research Institute, Marshfield, Wisconsin, USA.
Jackson ML; Kaiser Permanente Washington Health Research Institute, Seattle, Washington, USA.
Jackson LA; Kaiser Permanente Washington Health Research Institute, Seattle, Washington, USA.
Patel M; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Pokaż więcej
Źródło :
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 Aug 02; Vol. 73 (3), pp. 497-505.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.
MeSH Terms :
Influenza A Virus, H1N1 Subtype*
Influenza Vaccines*
Influenza, Human*/prevention & control
Child ; Humans ; Influenza A Virus, H3N2 Subtype ; Influenza B virus ; Seasons ; United States/epidemiology ; Vaccination
Czasopismo naukowe
Tytuł :
Seasonal influenza vaccination does not effectively expand H2 cross-reactive antibodies in humans.
Autorzy :
Beau Reneer Z; Center for Vaccines and Immunology, University of Georgia, Athens, GA, USA; Department of Infectious Diseases, University of Georgia, Athens, GA, USA.
Abreu RB; Center for Vaccines and Immunology, University of Georgia, Athens, GA, USA.
Jamal US; Center for Vaccines and Immunology, University of Georgia, Athens, GA, USA.
Corn MR; Center for Vaccines and Immunology, University of Georgia, Athens, GA, USA.
Paugh JL; Center for Vaccines and Immunology, University of Georgia, Athens, GA, USA.
Ross TM; Center for Vaccines and Immunology, University of Georgia, Athens, GA, USA; Department of Infectious Diseases, University of Georgia, Athens, GA, USA. Electronic address: .
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2021 Jul 05; Vol. 39 (30), pp. 4173-4183. Date of Electronic Publication: 2021 Jun 12.
Typ publikacji :
Journal Article
MeSH Terms :
Influenza A Virus, H1N1 Subtype*
Influenza Vaccines*
Influenza, Human*/prevention & control
Antibodies, Neutralizing ; Antibodies, Viral ; Cross Reactions ; Hemagglutinin Glycoproteins, Influenza Virus ; Humans ; Influenza A Virus, H3N2 Subtype ; Seasons ; Vaccination
Czasopismo naukowe
Tytuł :
Comparison of hemagglutination inhibition and hemagglutinin pseudovirus neutralization titres in relation to protection against influenza in a mouse model.
Autorzy :
Huang Y; Office of Biostatistics and Epidemiology, FDA Center for Biologics Evaluation and Research, Silver Spring, MD, USA.
Lin Z; Office of Vaccines Research and Review, FDA Center for Biologics Evaluation and Research, Silver Spring, MD, USA.
Wang W; Office of Vaccines Research and Review, FDA Center for Biologics Evaluation and Research, Silver Spring, MD, USA.
Weiss C; Office of Vaccines Research and Review, FDA Center for Biologics Evaluation and Research, Silver Spring, MD, USA.
Xie H; Office of Vaccines Research and Review, FDA Center for Biologics Evaluation and Research, Silver Spring, MD, USA.
Forshee RA; Office of Biostatistics and Epidemiology, FDA Center for Biologics Evaluation and Research, Silver Spring, MD, USA.
Pokaż więcej
Źródło :
Letters in applied microbiology [Lett Appl Microbiol] 2021 Sep; Vol. 73 (3), pp. 294-299. Date of Electronic Publication: 2021 Jun 11.
Typ publikacji :
Journal Article
MeSH Terms :
Influenza Vaccines*
Influenza, Human*/prevention & control
Animals ; Antibodies, Neutralizing ; Antibodies, Viral ; Hemagglutination ; Hemagglutinin Glycoproteins, Influenza Virus ; Hemagglutinins ; Humans ; Influenza A Virus, H3N2 Subtype ; Mice
Czasopismo naukowe
Tytuł :
Moderately pathogenic maternal influenza A virus infection disrupts placental integrity but spares the fetal brain.
Autorzy :
Antonson AM; Institute for Behavioral Medicine Research, The Ohio State University, Columbus, OH, USA; Department of Psychiatry & Behavioral Health, The Ohio State University, Columbus, OH, USA; Biosciences Division, College of Dentistry, The Ohio State University, Columbus, OH, USA; Infectious Diseases Institute, The Ohio State University, Columbus, OH, USA; Department of Animal Sciences, University of Illinois at Urbana-Champaign, Urbana, IL, USA. Electronic address: .
Kenney AD; Infectious Diseases Institute, The Ohio State University, Columbus, OH, USA; Department of Microbial Infection and Immunity, The Ohio State University, Columbus, OH, USA.
Chen HJ; Institute for Behavioral Medicine Research, The Ohio State University, Columbus, OH, USA; Department of Psychiatry & Behavioral Health, The Ohio State University, Columbus, OH, USA; Medical Scientist Training Program, The Ohio State University, Columbus, OH, USA; Department of Neuroscience, The Ohio State University, Columbus, OH, USA.
Corps KN; Department of Veterinary Biosciences, The Ohio State University, Columbus, OH, USA.
Yount JS; Infectious Diseases Institute, The Ohio State University, Columbus, OH, USA; Department of Microbial Infection and Immunity, The Ohio State University, Columbus, OH, USA.
Gur TL; Institute for Behavioral Medicine Research, The Ohio State University, Columbus, OH, USA; Department of Psychiatry & Behavioral Health, The Ohio State University, Columbus, OH, USA; Infectious Diseases Institute, The Ohio State University, Columbus, OH, USA; Medical Scientist Training Program, The Ohio State University, Columbus, OH, USA; Department of Neuroscience, The Ohio State University, Columbus, OH, USA; Department of Obstetrics & Gynecology, The Ohio State University, Columbus, OH, USA. Electronic address: .
Pokaż więcej
Źródło :
Brain, behavior, and immunity [Brain Behav Immun] 2021 Aug; Vol. 96, pp. 28-39. Date of Electronic Publication: 2021 May 12.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Influenza A virus*
Influenza, Human*
Animals ; Brain ; Female ; Humans ; Influenza A Virus, H3N2 Subtype ; Mice ; Placenta ; Pregnancy
Czasopismo naukowe
Tytuł :
From virus to inflammation, how influenza promotes lung damage.
Autorzy :
Klomp M; Department of Biomedical Sciences, School of Medicine and Health Sciences, University of North Dakota, Grand Forks, North Dakota, USA.
Ghosh S; Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio, USA.
Mohammed S; Department of Biomedical Sciences, University of North Dakota, USA.
Nadeem Khan M; Department of Biomedical Sciences, School of Medicine and Health Sciences, University of North Dakota, Grand Forks, North Dakota, USA.
Pokaż więcej
Źródło :
Journal of leukocyte biology [J Leukoc Biol] 2021 Jul; Vol. 110 (1), pp. 115-122. Date of Electronic Publication: 2020 Sep 08.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Influenza A virus*/immunology
Influenza, Human/*metabolism
Influenza, Human/*virology
Lung/*metabolism
Lung/*virology
Acute Lung Injury/etiology ; Acute Lung Injury/metabolism ; Acute Lung Injury/pathology ; Animals ; Disease Susceptibility ; Humans ; Influenza, Human/immunology ; Influenza, Human/pathology ; Lung/immunology ; Lung/pathology
Czasopismo naukowe
Tytuł :
Incidence of Medically Attended Acute Respiratory Illnesses Due to Respiratory Viruses Across the Life Course During the 2018/19 Influenza Season.
Autorzy :
Jackson ML; Kaiser Permanente Washington Health Research Institute, Kaiser Permanente Washington, Seattle, Washington, USA.
Starita L; Department of Genome Sciences, University of Washington, Seattle, Washington, USA.
Kiniry E; Kaiser Permanente Washington Health Research Institute, Kaiser Permanente Washington, Seattle, Washington, USA.
Phillips CH; Kaiser Permanente Washington Health Research Institute, Kaiser Permanente Washington, Seattle, Washington, USA.
Wellwood S; Kaiser Permanente Washington Health Research Institute, Kaiser Permanente Washington, Seattle, Washington, USA.
Cho S; Department of Genome Sciences, University of Washington, Seattle, Washington, USA.
Kiavand A; Department of Genome Sciences, University of Washington, Seattle, Washington, USA.
Truong M; Department of Genome Sciences, University of Washington, Seattle, Washington, USA.
Han P; Department of Genome Sciences, University of Washington, Seattle, Washington, USA.
Richardson M; Department of Genome Sciences, University of Washington, Seattle, Washington, USA.
Wolf CR; Department of Medicine, University of Washington, Seattle, Washington, USA.
Heimonen J; Department of Medicine, University of Washington, Seattle, Washington, USA.
Nickerson DA; Department of Genome Sciences, University of Washington, Seattle, Washington, USA.
Chu HY; Department of Medicine, University of Washington, Seattle, Washington, USA.
Pokaż więcej
Corporate Authors :
Seattle Flu Study Investigators
Źródło :
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 Sep 07; Vol. 73 (5), pp. 802-807.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
COVID-19*
Influenza A Virus, H1N1 Subtype*
Influenza, Human*/epidemiology
Respiratory Syncytial Virus, Human*
Respiratory Tract Infections*/epidemiology
Adult ; Child ; Humans ; Incidence ; Infant ; Influenza A Virus, H3N2 Subtype ; SARS-CoV-2 ; Seasons
Czasopismo naukowe
Tytuł :
A M2 protein-based universal influenza vaccine containing Advax-SM adjuvant provides newborn protection via maternal or neonatal immunization.
Autorzy :
Sakala IG; Vaxine Pty Ltd, 11 Walkley Avenue, Adelaide 5046, Australia; College of Medicine and Public Health, Flinders University, Adelaide 5042, Australia.
Honda-Okubo Y; Vaxine Pty Ltd, 11 Walkley Avenue, Adelaide 5046, Australia; College of Medicine and Public Health, Flinders University, Adelaide 5042, Australia.
Li L; Vaxine Pty Ltd, 11 Walkley Avenue, Adelaide 5046, Australia; College of Medicine and Public Health, Flinders University, Adelaide 5042, Australia.
Baldwin J; Vaxine Pty Ltd, 11 Walkley Avenue, Adelaide 5046, Australia.
Petrovsky N; Vaxine Pty Ltd, 11 Walkley Avenue, Adelaide 5046, Australia; College of Medicine and Public Health, Flinders University, Adelaide 5042, Australia. Electronic address: .
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2021 Aug 23; Vol. 39 (36), pp. 5162-5172. Date of Electronic Publication: 2021 Aug 03.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Influenza A Virus, H1N1 Subtype*
Influenza Vaccines*
Orthomyxoviridae Infections*/prevention & control
Animals ; Antibodies, Viral ; Female ; Immunization ; Influenza A Virus, H3N2 Subtype ; Inulin/analogs & derivatives ; Mice ; Mice, Inbred BALB C ; Viral Matrix Proteins
Czasopismo naukowe
Tytuł :
Body mass index and vaccine responses following influenza vaccination during pregnancy.
Autorzy :
Clarke M; Women's and Children's Health Network, North Adelaide, SA, Australia; Adelaide Medical School and The Robinson Research Institute, The University of Adelaide, Adelaide, SA, Australia. Electronic address: .
Goodchild LM; Women's and Children's Health Network, North Adelaide, SA, Australia. Electronic address: .
Evans S; Women's and Children's Health Network, North Adelaide, SA, Australia. Electronic address: .
Giles LC; School of Public Health and The Robinson Research Institute, The University of Adelaide, Adelaide, SA, Australia. Electronic address: .
Sullivan SG; WHO Collaborating Centre for Reference and Research on Influenza, Royal Melbourne Hospital, at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia; Department of Infectious Diseases, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia; Department of Epidemiology, University of California, Los Angeles, USA. Electronic address: .
Barr IG; WHO Collaborating Centre for Reference and Research on Influenza, Royal Melbourne Hospital, at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia; Department of Microbiology and Immunology, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia. Electronic address: .
Lambert S; Child Health Research Centre, The University of Queensland, South Brisbane, QLD, Australia. Electronic address: .
Marshall H; Women's and Children's Health Network, North Adelaide, SA, Australia; Adelaide Medical School and The Robinson Research Institute, The University of Adelaide, Adelaide, SA, Australia. Electronic address: .
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2021 Aug 09; Vol. 39 (34), pp. 4864-4870. Date of Electronic Publication: 2021 Jul 12.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Influenza A Virus, H1N1 Subtype*
Influenza Vaccines*
Influenza, Human*/prevention & control
Antibodies, Viral ; Body Mass Index ; Child ; Female ; Humans ; Infant ; Infant, Newborn ; Influenza A Virus, H3N2 Subtype ; Pregnancy ; Vaccination
Czasopismo naukowe
Tytuł :
Protective efficacy of a polyvalent influenza A DNA vaccine against both homologous (H1N1pdm09) and heterologous (H5N1) challenge in the ferret model.
Autorzy :
Guilfoyle K; National Institute for Biological Standards and Control (NIBSC), Blanche Lane, South Mimms, Potters Bar, EN6 3QG Hertfordshire, UK; Viroclinics Xplore, Nistelrooise Baan 3, 5374 Schaijk, The Netherlands(1).
Major D; National Institute for Biological Standards and Control (NIBSC), Blanche Lane, South Mimms, Potters Bar, EN6 3QG Hertfordshire, UK.
Skeldon S; National Institute for Biological Standards and Control (NIBSC), Blanche Lane, South Mimms, Potters Bar, EN6 3QG Hertfordshire, UK.
James H; National Institute for Biological Standards and Control (NIBSC), Blanche Lane, South Mimms, Potters Bar, EN6 3QG Hertfordshire, UK.
Tingstedt JL; Virus Research and Development Laboratory, Department of Virus and Microbiological Special Diagnostics, Statens Serum Institut, Artillerivej 5, 2300 Copenhagen S, Denmark.
Polacek C; Virus Research and Development Laboratory, Department of Virus and Microbiological Special Diagnostics, Statens Serum Institut, Artillerivej 5, 2300 Copenhagen S, Denmark.
Lassauniére R; Virus Research and Development Laboratory, Department of Virus and Microbiological Special Diagnostics, Statens Serum Institut, Artillerivej 5, 2300 Copenhagen S, Denmark.
Engelhardt OG; National Institute for Biological Standards and Control (NIBSC), Blanche Lane, South Mimms, Potters Bar, EN6 3QG Hertfordshire, UK. Electronic address: .
Fomsgaard A; Virus Research and Development Laboratory, Department of Virus and Microbiological Special Diagnostics, Statens Serum Institut, Artillerivej 5, 2300 Copenhagen S, Denmark; Infectious Disease Research Unit, Clinical Institute, University of Southern Denmark, Sdr. Boulevard 29, DK-5000 Odense C, Denmark.
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2021 Aug 09; Vol. 39 (34), pp. 4903-4913. Date of Electronic Publication: 2020 Oct 06.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Influenza A Virus, H1N1 Subtype*
Influenza A Virus, H5N1 Subtype*
Influenza Vaccines*
Influenza, Human*
Orthomyxoviridae Infections*/prevention & control
Vaccines, DNA*
Animals ; Antibodies, Viral ; Ferrets ; Humans ; Influenza A Virus, H3N2 Subtype ; Vaccines, Combined
Czasopismo naukowe
Tytuł :
Influenza vaccine effectiveness against influenza-associated hospitalization in children in Hong Kong, 2010-2020.
Autorzy :
Chua H; WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region.
Kwan MYW; Department of Paediatrics and Adolescent Medicine, Princess Margaret Hospital, Hong Kong Special Administrative Region.
Chan ELY; Department of Paediatrics and Adolescent Medicine, Queen Mary Hospital and Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region.
Wong JSC; Department of Paediatrics and Adolescent Medicine, Princess Margaret Hospital, Hong Kong Special Administrative Region.
Peiris JSM; WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region.
Cowling BJ; WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region. Electronic address: .
Chiu SS; Department of Paediatrics and Adolescent Medicine, Queen Mary Hospital and Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region.
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2021 Aug 09; Vol. 39 (34), pp. 4842-4848. Date of Electronic Publication: 2021 Jul 21.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Influenza A Virus, H1N1 Subtype*
Influenza Vaccines*
Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
Case-Control Studies ; Child ; Hong Kong/epidemiology ; Hospitalization ; Humans ; Influenza A Virus, H3N2 Subtype ; Seasons ; Vaccination
Czasopismo naukowe
Tytuł :
Influenza Vaccine Effectiveness in Inpatient and Outpatient Settings in the United States, 2015-2018.
Autorzy :
Tenforde MW; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Chung J; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Smith ER; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.; Oak Ridge Institute for Science and Education, Oak Ridge, Tennessee, USA.
Talbot HK; Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Trabue CH; University of Tennessee Health Science Center, Saint Thomas Health, Nashville, Tennessee, USA.
Zimmerman RK; University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Silveira FP; University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Gaglani M; Baylor Scott and White Health, Texas A&M University College of Medicine, Temple, Texas, USA.
Murthy K; Baylor Scott and White Health, Texas A&M University College of Medicine, Temple, Texas, USA.
Monto AS; University of Michigan School of Public Health, Ann Arbor, Michigan, USA.
Martin ET; University of Michigan School of Public Health, Ann Arbor, Michigan, USA.
McLean HQ; Marshfield Clinic Research Institute, Marshfield, Wisconsin, USA.
Belongia EA; Marshfield Clinic Research Institute, Marshfield, Wisconsin, USA.
Jackson LA; Kaiser Permanente Washington Health Research Institute, Seattle, Washington, USA.
Jackson ML; Kaiser Permanente Washington Health Research Institute, Seattle, Washington, USA.
Ferdinands JM; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Flannery B; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Patel MM; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Pokaż więcej
Źródło :
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 Aug 02; Vol. 73 (3), pp. 386-392.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.
MeSH Terms :
Influenza A Virus, H1N1 Subtype*
Influenza Vaccines*
Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
Adult ; Humans ; Influenza A Virus, H3N2 Subtype ; Inpatients ; Outpatients ; Seasons ; United States/epidemiology ; Vaccination
Czasopismo naukowe
Tytuł :
Natural influenza infection produces a greater diversity of humoral responses than vaccination in immunosuppressed transplant recipients.
Autorzy :
Hirzel C; Transplant Infectious Diseases and Multi-Organ Transplant Program, University Health Network, Toronto, Ontario, Canada.; Department of Infectious Diseases, Bern University Hospital, University of Bern, Bern, Switzerland.
Chruscinski A; Toronto General Hospital Research Institute, University Health Network, Toronto, Ontario, Canada.
Ferreira VH; Transplant Infectious Diseases and Multi-Organ Transplant Program, University Health Network, Toronto, Ontario, Canada.
L'Huillier AG; Pediatric Infectious Diseases Unit, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.
Natori Y; Division of Infectious Diseases, University of Miami, Miami, Florida, USA.
Han SH; University of South Korea, Seoul, South Korea.
Cordero E; Hospital Universitario Virgen del Rocío and Biomedicine Research Institute, Seville, Spain.; Spanish Network for Research in Infectious Diseases (REIPI, Seville, Spain.
Humar A; Transplant Infectious Diseases and Multi-Organ Transplant Program, University Health Network, Toronto, Ontario, Canada.
Kumar D; Transplant Infectious Diseases and Multi-Organ Transplant Program, University Health Network, Toronto, Ontario, Canada.
Pokaż więcej
Corporate Authors :
Influenza in Transplant Study Group
Źródło :
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons [Am J Transplant] 2021 Aug; Vol. 21 (8), pp. 2709-2718. Date of Electronic Publication: 2021 Feb 18.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Influenza A Virus, H1N1 Subtype*
Influenza Vaccines*
Influenza, Human*/prevention & control
Antibodies, Viral ; Humans ; Influenza A Virus, H3N2 Subtype ; Transplant Recipients ; Vaccination
Czasopismo naukowe
Tytuł :
Universal influenza vaccine based on conserved antigens provides long-term durability of immune responses and durable broad protection against diverse challenge virus strains in mice.
Autorzy :
Lo CY; Division of Cellular and Gene Therapies, Office of Tissues and Advanced Therapies, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.
Misplon JA; Division of Cellular and Gene Therapies, Office of Tissues and Advanced Therapies, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.
Li X; Division of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.
Price GE; Division of Cellular and Gene Therapies, Office of Tissues and Advanced Therapies, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.
Ye Z; Division of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.
Epstein SL; Division of Cellular and Gene Therapies, Office of Tissues and Advanced Therapies, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA. Electronic address: .
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2021 Jul 30; Vol. 39 (33), pp. 4628-4640. Date of Electronic Publication: 2021 Jul 03.
Typ publikacji :
Journal Article; Research Support, U.S. Gov't, P.H.S.
MeSH Terms :
Influenza A Virus, H7N9 Subtype*
Influenza Vaccines*
Orthomyxoviridae Infections*/prevention & control
Animals ; Antibodies, Viral ; Hemagglutinin Glycoproteins, Influenza Virus/genetics ; Immunity ; Mice ; Mice, Inbred BALB C ; Vaccination
Czasopismo naukowe
Tytuł :
Expression of Surfactant Protein D Distinguishes Severe Pandemic Influenza A(H1N1) from Coronavirus Disease 2019.
Autorzy :
Choreño-Parra JA; Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City, Mexico.; Laboratorio de Inmunobiología y Genética, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.
Jiménez-Álvarez LA; Laboratorio de Inmunobiología y Genética, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.
Ramírez-Martínez G; Laboratorio de Inmunobiología y Genética, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.
Cruz-Lagunas A; Laboratorio de Inmunobiología y Genética, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.
Thapa M; Department of Pathology and Immunology, Washington University School of Medicine, St Louis, Missouri, USA.
Fernández-López LA; Laboratorio de Inmunobiología y Genética, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.
Carnalla-Cortés M; Centro de Investigación en Salud Poblacional, Instituto Nacional de Salud Pública. Cuernavaca, Morelos, Mexico.
Choreño-Parra EM; Posgrado en Ciencias Biológicas, Universidad Nacional Autónoma de México, Mexico City, Mexico.
Mena-Hernández L; Department of Dermatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Sandoval-Vega M; Facultad de Estudios Superiores Iztacala, Universidad Nacional Autónoma de México, Tlalnepantla de Baz, Mexico.
Hernández-Montiel EM; Laboratorio de Inmunobiología y Genética, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.; Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Mexico City, Mexico.
Hernández-García DL; Respiratory Critical Care Unit, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.
Ramírez-Noyola JA; Laboratorio de Inmunobiología y Genética, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.; Facultad de Estudios Superiores Iztacala, Universidad Nacional Autónoma de México, Tlalnepantla de Baz, Mexico.
Reyes-López CE; Laboratorio de Inmunobiología y Genética, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.; Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Mexico City, Mexico.
Domínguez-Faure A; Laboratorio de Inmunobiología y Genética, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.; Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Mexico City, Mexico.
Zamudio-López GY; Laboratorio de Inmunobiología y Genética, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.
Márquez-García E; Laboratorio de Inmunobiología y Genética, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.
Moncada-Morales A; Laboratorio de Inmunobiología y Genética, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.
Mendoza-Milla C; Departamento de Fibrosis Pulmonar, Instituto Nacional de Enfermedades Respiratorias Isamel Cosío Villegas, Mexico City, Mexico.
Cervántes-Rosete D; Deparment of Immunology and Reumathology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Muñoz-Torrico M; Clínica de Tuberculosis, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.
Luna-Rivero C; Department of Pathology, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.
García-Latorre EA; Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City, Mexico.
Guadarrama-Ortíz P; Centro Especializado en Neurocirugía y Neurociencias México (CENNM), Mexico City, Mexico.
Ávila-Moreno F; Biomedicine Research Unit, Lung Diseases and Cancer Epigenomics Laboratory, Facultad de Estudios Superiores Iztacala, Universidad Nacional Autónoma de México, Tlalnepantla de Baz, Mexico.
Domínguez-Cherit G; Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Mexico City, Mexico.; Intensive Care Unit, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Rodríguez-Reyna TS; Deparment of Immunology and Reumathology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Mudd PA; Department of Emergency Medicine, Washington University School of Medicine in St Louis, Missouri, USA.
Hernández-Cárdenas CM; Respiratory Critical Care Unit, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.
Khader SA; Department of Molecular Microbiology, Washington University School of Medicine in St Louis, Missouri, USA.
Zúñiga J; Laboratorio de Inmunobiología y Genética, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.; Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Mexico City, Mexico.
Pokaż więcej
Źródło :
The Journal of infectious diseases [J Infect Dis] 2021 Jul 02; Vol. 224 (1), pp. 21-30.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Gene Expression*
Influenza A Virus, H1N1 Subtype*
SARS-CoV-2*
COVID-19/*genetics
Host-Pathogen Interactions/*genetics
Influenza, Human/*genetics
Pulmonary Surfactant-Associated Protein D/*genetics
Adult ; Aged ; Biomarkers ; COVID-19/blood ; COVID-19/diagnosis ; COVID-19/virology ; Coinfection ; Enzyme-Linked Immunosorbent Assay ; Female ; Humans ; Influenza, Human/diagnosis ; Influenza, Human/virology ; Male ; Middle Aged ; Prognosis ; Pulmonary Surfactant-Associated Protein D/blood ; Severity of Illness Index ; Symptom Assessment ; Young Adult
Czasopismo naukowe
Tytuł :
Effect of Influenza Vaccination in Preventing Laboratory-Confirmed Influenza Hospitalization in Patients With Diabetes Mellitus.
Autorzy :
Martínez-Baz I; Instituto de Salud Pública de Navarra - IdiSNA, Pamplona, Spain.; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Navascués A; Clinical Microbiology Department, Complejo Hospitalario de Navarra - IdiSNA, Pamplona, Spain.
Portillo ME; Clinical Microbiology Department, Complejo Hospitalario de Navarra - IdiSNA, Pamplona, Spain.
Casado I; Instituto de Salud Pública de Navarra - IdiSNA, Pamplona, Spain.; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Fresán U; Instituto de Salud Pública de Navarra - IdiSNA, Pamplona, Spain.; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Ezpeleta C; Clinical Microbiology Department, Complejo Hospitalario de Navarra - IdiSNA, Pamplona, Spain.
Castilla J; Instituto de Salud Pública de Navarra - IdiSNA, Pamplona, Spain.; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Pokaż więcej
Źródło :
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 Jul 01; Vol. 73 (1), pp. 107-114.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Diabetes Mellitus*/epidemiology
Influenza A Virus, H1N1 Subtype*
Influenza Vaccines*
Influenza, Human*/complications
Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
Aged ; Case-Control Studies ; Hospitalization ; Humans ; Influenza A Virus, H3N2 Subtype ; Laboratories ; Seasons ; Spain/epidemiology ; Vaccination
Czasopismo naukowe
Tytuł :
A Reduced Dose Whole Virion Aluminum Adjuvanted Seasonal Influenza Vaccine Is Immunogenic, Safe, and Well Tolerated in Pediatric Patients.
Autorzy :
Vajo Z; Department of Family Medicine, Semmelweis University Medical School, 1125 Budapest, Hungary.
Balaton G; Department of Pediatric Dentistry, Semmelweis University Medical School, 1088 Budapest, Hungary.
Vajo P; Clinical Center, University of Debrecen, 4032 Debrecen, Hungary.
Torzsa P; Department of Family Medicine, Semmelweis University Medical School, 1125 Budapest, Hungary.
Pokaż więcej
Źródło :
Viruses [Viruses] 2021 Mar 18; Vol. 13 (3). Date of Electronic Publication: 2021 Mar 18.
Typ publikacji :
Clinical Trial; Journal Article; Multicenter Study
MeSH Terms :
Adjuvants, Immunologic*/administration & dosage
Adjuvants, Immunologic*/adverse effects
Aluminum Compounds*/administration & dosage
Aluminum Compounds*/adverse effects
Influenza Vaccines*/administration & dosage
Influenza Vaccines*/adverse effects
Phosphates*/administration & dosage
Phosphates*/adverse effects
Influenza, Human/*prevention & control
Adolescent ; Child ; Child, Preschool ; Female ; Humans ; Hungary/epidemiology ; Influenza A Virus, H1N1 Subtype/immunology ; Influenza A Virus, H3N2 Subtype/immunology ; Influenza B virus/immunology ; Male ; Prospective Studies ; Virion/immunology
Czasopismo naukowe
Tytuł :
Development of influenza-associated disease burden pyramid in Shanghai, China, 2010-2017: a Bayesian modelling study.
Autorzy :
Li J; School of Public Health, Fudan University, Shanghai, Shanghai, China.; Renal Division, Peking University Shenzhen Hospital, Shenzhen, Guangdong, China.; Clinical Research Academy, Peking University Shenzhen Hospital, Shenzhen, Guangdong, China.
Wang C; Department of Vital Statistics, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, China.
Ruan L; Research Base of Key Laboratory of Surveillance and Early Warning on Infectious Disease, Pudong New Area Center for Disease Control and Prevention, Shanghai, China.
Jin S; Department of Vital Statistics, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, China.
Ye C; Research Base of Key Laboratory of Surveillance and Early Warning on Infectious Disease, Pudong New Area Center for Disease Control and Prevention, Shanghai, China.
Yu H; Department of Vital Statistics, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, China.
Zhu W; Research Base of Key Laboratory of Surveillance and Early Warning on Infectious Disease, Pudong New Area Center for Disease Control and Prevention, Shanghai, China .
Wang X; School of Public Health, Fudan University, Shanghai, Shanghai, China .; Shanghai Key Laboratory of Meteorology and Health, Shanghai, China.
Pokaż więcej
Źródło :
BMJ open [BMJ Open] 2021 Sep 08; Vol. 11 (9), pp. e047526. Date of Electronic Publication: 2021 Sep 08.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Influenza A Virus, H1N1 Subtype*
Influenza, Human*/epidemiology
Aged ; Bayes Theorem ; China/epidemiology ; Cost of Illness ; Humans ; Influenza A Virus, H3N2 Subtype ; Seasons
Czasopismo naukowe
Tytuł :
Comparison of clinical characteristics and outcomes between respiratory syncytial virus and influenza-related pneumonia in China from 2013 to 2019.
Autorzy :
Chen L; Department of Infectious Diseases, Beijing Jishuitan Hospital, 4th Medical College of Peking University, Beijing, China. .
Han X; Department of Pulmonary and Critical Care Medicine, Qingdao Municipal Hospital, Qingdao City, Shandong Province, China.
Li Y; Department of Infectious Diseases and Clinical Microbiology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.
Zhang C; Department of Pulmonary and Critical Care Medicine, Beijing Huimin Hospital, Beijing, China.
Xing X; Department of Pulmonary and Critical Care Medicine, The Second People's Hospital of Yunnan Province, Kunming City, Yunnan Province, China.
Pokaż więcej
Źródło :
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology [Eur J Clin Microbiol Infect Dis] 2021 Aug; Vol. 40 (8), pp. 1633-1643. Date of Electronic Publication: 2021 Mar 06.
Typ publikacji :
Journal Article
MeSH Terms :
Influenza A virus*
Respiratory Syncytial Viruses*
Influenza, Human/*complications
Pneumonia, Viral/*virology
Respiratory Syncytial Virus Infections/*complications
China/epidemiology ; Female ; Humans ; Influenza, Human/virology ; Logistic Models ; Male ; Middle Aged ; Multivariate Analysis ; Pneumonia, Viral/epidemiology ; Retrospective Studies ; Risk Factors
Czasopismo naukowe
Tytuł :
[Epidemiological characteristics of influenza and characteristics of hemagglutinin gene of B-Victoria strains in Hebei Province from 2018 to 2019].
Autorzy :
Han GY; Institute of Prevention and Treatment for Viral Diseases,Hebei Center for Disease Control and Prevention,Shijiazhuang 050021, China.
Li Y; Institute of Prevention and Treatment for Viral Diseases,Hebei Center for Disease Control and Prevention,Shijiazhuang 050021, China.
Jiang CX; Institute of Prevention and Treatment for Viral Diseases,Hebei Center for Disease Control and Prevention,Shijiazhuang 050021, China.
Liu YF; Institute of Prevention and Treatment for Viral Diseases,Hebei Center for Disease Control and Prevention,Shijiazhuang 050021, China.
Liu LF; Institute of Prevention and Treatment for Viral Diseases,Hebei Center for Disease Control and Prevention,Shijiazhuang 050021, China.
Qi SX; Institute of Prevention and Treatment for Viral Diseases,Hebei Center for Disease Control and Prevention,Shijiazhuang 050021, China.
Pokaż więcej
Źródło :
Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine] [Zhonghua Yu Fang Yi Xue Za Zhi] 2021 Jul 06; Vol. 55 (7), pp. 847-852.
Typ publikacji :
Journal Article
MeSH Terms :
Influenza A Virus, H1N1 Subtype*
Influenza, Human*/epidemiology
Hemagglutinin Glycoproteins, Influenza Virus/genetics ; Hemagglutinins ; Humans ; Phylogeny
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies